Serotype-specific probes for Listeria monocytogenes

Details Serotype-specific probes for Listeria monocytogenes Serotype-specific probes for Listeria monocytogenes

1998-07-14

2003-01-07

Myers, Carla J. (Department: 1634)

Chemistry: molecular biology and microbiology

Micro-organism, per se ; compositions thereof; proces of...

Bacteria or actinomycetales; media therefor

C435S325000, C435S320100, C536S023100, C536S024320, C536S023700

Reexamination Certificate

active

06503747

ABSTRACT:

FIELD OF THE INVENTION
The present invention relates to the identification and characterization of novel DNA sequences that are specific to
Listeria monocytogenes
strains that are commonly associated with human disease and provides improved oligonucleotides and methods for their use in the detection and typing of these strains.
BACKGROUND
Listeria monocytogenes,
a bacterium, is the causative agent of listeriosis, a serious disease of humans and animals that can be transmitted by means of contaminated food. Newborns, the elderly, and immunocompromised individuals are especially prone to infection. Listeria are commonly found in the environment and, unlike most other human pathogens, are capable of growth at refrigeration temperatures, often leading to problematic contamination of cold-stored foods. Such foods, especially dairy products, have been implicated in numerous cases of sporadic listeriosis as well as several common-source epidemics of the disease.
Even though numerous serotypes of
L. monocytogenes
have been identified with the antigenic scheme of Seeliger and Höhne (Methods Microbiol. 13:31-49 (1979)), three serotypes (1/2a, 1/2b, and 4b) account for the vast majority of clinical isolates. Furthermore, strains of serotype 4b have been implicated in a large fraction (ca. 40%) of sporadic listeriosis cases and virtually all common-source outbreaks reported in Europe and North America during the past 20 years (Schuchat et al. 1991. Clin. Microbiol. Rev. 4:169-183). Pulsed-field fingerprinting of chromosomal DNA has revealed that serotypes 4b, 4d, and 4e strains constitute one genomic subdivision (cluster IIB) (Brosh et al. 1994. Appl. Environ. Microbiol. 60:2584-2592). From the perspective of human disease, serotype 4b strains are the major component of this genomic cluster because serotype 4d and 4e strains are isolated only rarely from foods and virtually never from patients (Farber et al., 1991. Microbiol. Rev. 55:476-511).
Serologic methods currently employed to type strains of
Listeria monocytogenes
requires culturing and isolating the bacteria and highly specific antisera. These techniques are performed effectively only in a small number of reference laboratories (Seeliger and Hohne. 1979. Methods Microbiol. 13:31-49). Monoclonal antibodies have been described that are specific for individual serotypes; however, because monoclonal antibodies are highly specific, subtle variations in epitope structure can render them non-reactive. Existing hybridization and PCR-based methodologies employing oligonucleotides have been described to identify
Listeria monocytogenes
but these methods can not be used to identify individual strains and serotypes most commonly associated with human disease because the nucleic acids targeted by the oligonucleotides are shared across serotypes. As described above, pulse-field fingerprinting has been used to identify
L. monocytogenes
genomic divisions, which have been correlated with individual serovars and subgroups but this technique is not amenable to routine analysis because it requires expensive equipment to run the assay and analyze the data, and is labor intensive. It would, therefore, be useful to identify and characterize genetic and molecular features unique to
L. monocytogenes
serotypes to facilitate the development of methods and reagents for molecular subtyping and detection of strains most commonly associated with human disease.
SUMMARY OF THE INVENTION
The present invention provides compositions and methods for detecting and identifying
Listeria monocytogenes
genomic cluster IIB strains which are commonly associated with human disease.
In one embodiment the invention provides an isolated nucleic acid of
L. monocytogenes
genomic DNA that is unique to genomic cluster IIB strains.
In one aspect, the isolated nucleic acid comprises DNA having preferably at least about 80% sequence identity, and most preferably at least about 90% sequence identity to genomic cluster IIB DNA or its complement. In another aspect, the invention provides recombinant nucleic acids that hybridize to genomic cluster IIB-DNA. Preferably, hybridization occurs under stringent hybridization and wash conditions.
In another aspect the invention provides an isolated nucleic acid molecule comprising a DNA encoding one or more polypeptide(s) involved in the expression of cluster IIB polypeptides or its complement. The invention further provides antibody which specifically binds to a genomic cluster IIB polypeptide.
In a still further aspect the invention provides a vector comprising an isolated nucleic acid comprising genomic cluster IIB-DNA or its variants.
In yet another aspect the invention provides methods for detecting
L. monocytogenes
genomic cluster IIB in a composition of matter comprising cluster IIB specific nucleotide sequences. In a further aspect of the invention, oligonucleotide probes derived from the aforemention sequences and methods for their synthesis, labeling and use in the detection and identification of
L. monocytogenes
cluster IIB strains are provided. In a broad embodiment, the methods comprise contacting the nucleic acids of
L. monocytogenes
with one or more oligonucleotides under conditions permitting hybridization and detecting the hybridized oligonucleotide.


REFERENCES:
patent: 5089386 (1992-02-01), Stackebrandt et al.
patent: 5376528 (1994-12-01), King et al.
patent: 5389513 (1995-02-01), Banquero et al.
patent: 5491068 (1996-02-01), Benjamin et al.
patent: 5523205 (1996-06-01), Cossart et al.
patent: 5610012 (1997-03-01), Luchansky et al.
patent: 5627030 (1997-05-01), Pandian et al.
patent: 5695946 (1997-12-01), Benjamin et al.
patent: 5696232 (1997-12-01), Chakraborty et al.
patent: 5753467 (1998-05-01), Jensen et al.
patent: WO 96/24686 (1996-08-01), None
patent: 98/21225 (1998-05-01), None
Morona, R. et al. J. Bacteriol. 176(3):733-747, Feb. 1994.*
Gibco/BRL Life Technologies Catalogue and Reference Guide, 1993-94, p. R100.*
Kathariou et al., “The Type Strain(s) ofListeria monocytogenes: a Source of Continuing Difficulties,” International Journal of Systematic Bacteriology, 41(2):328-330 (1991).
Lei et al., EMBL Acc. No. AF033015, Jan. 6, 1999.
Zheng et al., “Differentiation of Epidemic-Associated Strains ofListeria monocytogenesby Restriction Fragment Length Polymorphism in a Gene Region Essential for Growth at Low Temperatures (4° C)”, Applied and Environmental Microbiology, 61(12):4310-4314 (1995).
Lei, Xiang-He et al., “Listeria monocytogenesSerotype 4b-Specific PCR Detection,” abstacts of the General Meeting of the American Society for Microbiology, 96(0):375 (1996).
Brosch et al., “Pulsed-Field Fingerprinting of Listeriae: Identification of Genomic Divisions forListeria monocytogenesand Their Correlation with Serovar,” Appl. Environ. Microbiol., 60(7):2584-2592 (Jul. 1994).
Lei et al., “DNA Fragments from Regions Involved in Surface Antigen Expression Specifically IdentifyListeria monocytogenesSerovar 4 and a Subset Thereof: Cluster IIB (Serotypes 4b, 4d, and 4e),” Appl. Environ. Microbiol., 63(3):1077-1082 (Mar. 1997).

Affiliated with

Also associated with

Rating

Serotype-specific probes for Listeria monocytogenes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Serotype-specific probes for Listeria monocytogenes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serotype-specific probes for Listeria monocytogenes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3046970